Posts

Posted on

Accenture Acquires Core Compete, Expands Capabilities and Talent in AI-powered Supply Chain, Cloud and Data Science

Accenture Acquires Core Compete, Expands Capabilities and Talent in AI-powered Supply Chain, Cloud and Data Science

NEW YORK–(BUSINESS WIRE)–
Accenture (NYSE: ACN) has acquired Core Compete, a cloud analytics services firm headquartered in Durham, North Carolina, with additional offices in the UK and India. Core Compete enables digital transformations with cloud-native solutions that deliver artificial intelligence (AI) and machine learning-infused business outcomes, to serve a diverse client base across the US and UK, with particular focus on supply chain, retail and financial services. Terms of the transaction were not disclosed.

Founded in 2012, Core Compete’s team of more than 260 professionals will join Accenture’s Applied Intelligence practice, strengthening how the company helps clients shape and execute their cloud-based data and AI strategies to drive more business value.

Powered by a deeply skilled group of data science, data engineering and cloud engineering consultants, the majority of whom have skills across all major cloud providers, Core Compete is well-positioned to meet a significant need in the market. Accenture research shows that two-thirds of CxOs are planning to increase spending on AI and over 60 percent will invest more in cloud-based technologies.

“Over the past year we’ve seen cloud adoption increase, enabling organizations to unlock the enterprise value from data and AI strategy at speed,” said Sanjeev Vohra, global lead for Accenture Applied Intelligence. “Core Compete’s approach to cloud analytics transformation helps us further accelerate time to value for our clients, giving them the right tools, strategy and talent to reap the full benefits of being data-driven.”

“We have always seen the power of cloud analytics and are proud of the client transformations we’ve led over the past nine years,” said Shiva Kommareddi, managing partner, Core Compete. “Accenture’s investment in cloud and focus on AI as an exponential source of value is exactly what we need to help broaden our impact across new markets and industries and deepen our impact with clients.”

This acquisition builds on Accenture’s growing analytics, data and AI business around the world, with the acquisitions of Analytics8 in Australia, Pragsis Bidoop in Spain, Mudano in the UK, Byte Prophecy in India, Sentelis in France, and Clarity Insights and End-to-End Analytics in the US.

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 537,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

Applied Intelligence is Accenture’s approach to scaling AI for clients by embedding AI-powered data, analytics and automation capabilities into business workflows, accelerating time to value with a powerful global alliance, innovation and delivery network that can deploy and scale AI within any market and industry. To learn more, visit www.accenture.com/appliedintelligence.

Forward-Looking Statements

Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “positioned,” “outlook” and similar expressions are used to identify these forward-looking statements. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied. Many of the following risks, uncertainties and other factors identified below are, and will be, amplified by the COVID-19 pandemic. These risks include, without limitation, risks that: the transaction might not achieve the anticipated benefits for Accenture; Accenture’s results of operations have been significantly adversely affected and could in the future be materially adversely impacted by the COVID-19 pandemic; Accenture’s results of operations have been, and may in the future be, adversely affected by volatile, negative or uncertain economic and political conditions and the effects of these conditions on the company’s clients’ businesses and levels of business activity; Accenture’s business depends on generating and maintaining ongoing, profitable client demand for the company’s services and solutions including through the adaptation and expansion of its services and solutions in response to ongoing changes in technology and offerings, and a significant reduction in such demand or an inability to respond to the evolving technological environment could materially affect the company’s results of operations; if Accenture is unable to keep its supply of skills and resources in balance with client demand around the world and attract and retain professionals with strong leadership skills, the company’s business, the utilization rate of the company’s professionals and the company’s results of operations may be materially adversely affected; Accenture could face legal, reputational and financial risks if the company fails to protect client and/or company data from security incidents or cyberattacks; the markets in which Accenture operates are highly competitive, and Accenture might not be able to compete effectively; Accenture’s profitability could materially suffer if the company is unable to obtain favorable pricing for its services and solutions, if the company is unable to remain competitive, if its cost-management strategies are unsuccessful or if it experiences delivery inefficiencies or fail to satisfy certain agreed-upon targets or specific service levels; changes in Accenture’s level of taxes, as well as audits, investigations and tax proceedings, or changes in tax laws or in their interpretation or enforcement, could have a material adverse effect on the company’s effective tax rate, results of operations, cash flows and financial condition; Accenture’s ability to attract and retain business and employees may depend on its reputation in the marketplace; as a result of Accenture’s geographically diverse operations and its growth strategy to continue to expand in its key markets around the world, the company is more susceptible to certain risks; Accenture’s business could be materially adversely affected if the company incurs legal liability; Accenture’s work with government clients exposes the company to additional risks inherent in the government contracting environment; Accenture’s results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates; if Accenture is unable to manage the organizational challenges associated with its size, the company might be unable to achieve its business objectives; if Accenture does not successfully manage and develop its relationships with key alliance partners or fails to anticipate and establish new alliances in new technologies, the company’s results of operations could be adversely affected; Accenture might not be successful at acquiring, investing in or integrating businesses, entering into joint ventures or divesting businesses; if Accenture is unable to protect or enforce its intellectual property rights or if Accenture’s services or solutions infringe upon the intellectual property rights of others or the company loses its ability to utilize the intellectual property of others, its business could be adversely affected; Accenture’s results of operations and share price could be adversely affected if it is unable to maintain effective internal controls; changes to accounting standards or in the estimates and assumptions Accenture makes in connection with the preparation of its consolidated financial statements could adversely affect its financial results; Accenture might be unable to access additional capital on favorable terms or at all and if the company raises equity capital, it may dilute its shareholders’ ownership interest in the company; Accenture may be subject to criticism and negative publicity related to its incorporation in Ireland; as well as the risks, uncertainties and other factors discussed under the “Risk Factors” heading in Accenture plc’s most recent Annual Report on Form 10-K and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture’s expectations.

Copyright © 2021 Accenture. All rights reserved. Accenture, and its logo are trademarks of Accenture.

Kathryn Rosati

Accenture

+1 917 452 6662

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Technology Consulting Other Technology Professional Services Software Networks Internet Data Management Other Professional Services

MEDIA:

Posted on

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2021 on Wednesday, April 28, 2021

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2021 on Wednesday, April 28, 2021

MARLBOROUGH, Mass.–(BUSINESS WIRE)–
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2021 on Wednesday, April 28, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

Interested participants may listen to the call by dialing 800-263-0877 (in the United States and Canada) or +1 323-794-2094 (for international callers) and referencing access code 7731175. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. A replay will be available approximately two hours after the call ends through Friday, May 21, 2021. The replay numbers are 888-203-1112 (U.S.) or +1 719-457-0820 (international), access code 7731175, PIN 5337.

Hologic will provide a live webcast of the call on the Company’s website at www.investors.hologic.com.

The call will be archived there for 30 days.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Paula Izidoro

Senior Investor Relations Specialist

(858) 410-8904

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Medical Devices Health Consumer Women General Health Biotechnology

MEDIA:

Logo
Logo
Posted on

The Tellabs 1000 MSAP’s new VDSL2 6+6B plug-in card underscores continued R&D investment

The Tellabs

®

1000 Multiservice Access Platform (MSAP), the industry’s only fiber-fed IP-enabled digital loop carrier, adds a new VDSL2 6+6B plug-in card for telco network modernizations

CARROLLTON, Texas, April 07, 2021 (GLOBE NEWSWIRE) — Tellabs, the leader in broadband access solutions for global telecommunications service providers, announces the Tellabs® 1000 Multiservice Access Platform (MSAP) Feature Package 17.0.8 (FP17.0.8), with its new Tellabs® VDSL2 6+6B plug-in card, have successfully completed its first office application deployment, are commercially available and shipping in quantities.

The purpose of the modernized Tellabs 1000 VDSL2 6+6B card is to help network operators:

  • Leverage Existing Tellabs 1000 MSAP – Deploy rapidly, utilizing embedded base, to meet funding requirements and market needs by capitalizing on using existing copper plant.
  • Expand Services Areas – Serve more subscribers with greater bandwidth while economically serving higher speed connectivity to both residential and business customers.
  • Provide More Premium Services – Deliver faster speeds to improve customer satisfaction and retention. Plus, increase premium service rates to generate more revenue.
  • Streamline Broadband Delivery – Our broadband service providers customers benefit from the better economics of operationalizing one card that does all modes of DSL technology.

The new Tellabs 1000 VDSL2 6+6B card features include:

  • Single card for all ADSL2+ and VDSL2 functions (VDSL2, VDSL2 bonding, ADSL2+, ADSL2+ bonding, ADSL2+ PTM and ADSL2)
  • Mix and match services on the same card, such as bonded and non-bonded lines
  • Six ports of integrated DSL data and POTS voice connectivity
  • Ability to deliver high-speed DSL speeds up to 100Mb/s
  • Provisioning via either Craft User Interface (CUI) and Tellabs® Panorama™ Element Management System (EMS)

“The Tellabs 1000 MSAP, with its updated VDSL2 6+6B card, is the best choice for network modernization for our longstanding telco service provider customers. The renewed VDSL2 6+6B card enables them to economically leverage existing operationalized access network infrastructure to better deliver broadband connectivity to their un-served and under-served residential and business customers,” said Mike Kavanagh, Tellabs Vice-President Telco Sales.

For more details about the Tellabs 1000 MSAP VDSL2 6+6B card, we invite you to access our online data sheet and you can click here to register for our May 19th 30-minute webcast “Economical and Easy Broadband DSL Connectivity with the Tellabs 1000 MSAP.“

About Tellabs

Tellabs is leading the future of networking with access solutions for today, poised to deliver modern high-performance solutions for the future. Fast and secure access has never been in more demand for service providers, enterprise and government connectivity. Tellabs’ sole focus is to deliver simple, secure, scalable and stable access to optimize network performance. Tellabs has delivered carrier-class access solutions to network operators for more than two decades. We are now expanding that leadership by defining the future of enterprise networking that connects the campus, buildings and inspires people. For more information, please visit www.tellabs.com/.

Media Contact

John Hoover
+1-707-206-1751
[email protected]



Posted on

Regulus Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference

PR Newswire

LA JOLLA, Calif., April 7, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the 20th Annual Needham Healtchare Conference on Thursday, April 15th at 1:30 P.M. ET.

A live webcast of the presentation will be available on the investor relations section of the Company’s website at www.regulusrx.com. A replay of the webcast will be archived for 30 days following the presentation date.

About Regulus

Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA. 

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus’ current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics and in the endeavor of building a business around such drugs, and feedback from the FDA. In addition, while Regulus expects the COVID-19 pandemic to adversely affect its business operations and financial results, the extent of the impact on Regulus’ ability to achieve its preclinical and clinical development objectives and the value of and market for its common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the U.S. and in other countries, and the effectiveness of actions taken globally to contain and treat the disease.   These and other risks are described in additional detail in Regulus’ filings with the Securities and Exchange Commission.  All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/regulus-therapeutics-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-301263805.html

SOURCE Regulus Therapeutics Inc.

Posted on

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders

Progress at the Heart grant program will award up to $125,000 in grants in recognition of World Health Day and National Minority Health Month

PR Newswire

PLYMOUTH MEETING, Pa., April 7, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the launch of a new grant program, Progress at the Heart, to accelerate programs and solutions that address inequity in access to diagnosis, treatment, and care in the rare disease and sleep disorder community.

Many people from underrepresented racial, ethnic, or other minority groups often face an even greater disparity in access to care, particularly given underrepresentation in research and clinical trials. In recognition of World Health Day and National Minority Health Month this April, Progress at the Heart seeks community- and education-based solutions and grant applications are currently being accepted. Up to $125,000 in grants will be awarded by September 2021 in an effort to help achieve greater equality of care within the sleep disorder community.

“Progress at the Heart is a natural extension of our grant programs and supports our mission to address the needs of those living with sleep disorders or rare diseases who experience sleep disruption and problems related to impaired wakefulness,” said Cate McCanless, Harmony’s Senior Vice President, Corporate Affairs and Policy. “Language barriers, real or perceived discrimination and bias, lack of access to resources and many more factors can contribute to the overall disparities experienced by racial, ethnic and other underrepresented minorities related to sleep health and sleep disorder diagnosis and treatment. We believe that through programs funded by Progress at the Heart grants, we will be able to recognize, realize and replicate effective interventions that address these disparities in the management of patients with sleep disorders, which, in turn, could reduce overall health disparities and improve quality of life for so many people.”

Harmony is accepting two rounds of grant applications in 2021 from April 7 – May 31 and from June 1 – August 20 which will be reviewed by a cross-functional team of Harmony employees. Grants will be awarded to applicants by the end of June and September 2021, respectively. For more information, please visit www.harmonybiosciences.com/grant-programs/progress-at-the-heart and submit grant applications to [email protected].

About Harmony Biosciences 
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare, neurological disorders who have unmet medical needs. For more information on Harmony Biosciences, please visit the company’s website: www.harmonybiosciences.com.

Harmony Biosciences Media Contact: 

Nancy Leone 
215-891-6046 
[email protected] 

Harmony Biosciences Investor Contact: 

Lisa Caperelli 
484-539-9736 
[email protected] 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/harmony-biosciences-launches-grant-program-to-address-inequities-in-the-delivery-of-healthcare-in-patients-with-sleep-disorders-301263519.html

SOURCE Harmony Biosciences

Posted on

U.S. Gold Corp. Announces New Targets for Upcoming Commencement of Drilling at Maggie Creek, Carlin Gold Belt, in Nevada

– U.S. Gold Corp. intends to drill up to 5,000 feet (approx. 1,500 m) in up to 2 holes as part of ongoing exploration

– These holes seek to assess a new target concept below post-mineral cover to the east of Nevada Gold Mines’ Gold Quarry mine

– Target was developed using structural projections, gravity data and geochemistry

PR Newswire

ELKO, Nev., April 7, 2021 /PRNewswire/ — U.S. Gold Corp. (NASDAQ: USAU), a gold exploration and development company, is pleased to announce plans for the commencement of core drill testing of a previously untested, covered Carlin-type target on its Maggie Creek project, located directly east of Nevada Gold Mines’ Gold Quarry mine and processing facilities.

Ken Coleman, U.S. Gold Corp.’s Chief Geologist, states, “We are very pleased to move forward with the initial assessment of this target concept in an area not previously tested due to thick post-mineral cover. Previous operators have looked at the property from the standpoint of shallow, open-pit mineable and heap leachable deposit exploration. We have seen over the recent years an increase in exploration under cover for potentially high-grade, underground mineable gold deposits along the Carlin and Battle Mountain-Eureka Gold Belts. I think high-grade, underground mining is the future in Nevada and that the best opportunities for major discoveries will be under cover. Pursuing these opportunities will require proper mapping and sound geologic reasoning, supported by geochemical and geophysical tools. While we will continue to assess near-surface opportunities on our various projects, we will also be placing a stronger emphasis on concealed targets in areas of our projects that have been lightly tested or not previously explored.”

Previous interpretations of the local structure and mineral potential of the Maggie Creek project have been based upon straight-line projections of the northeast striking Chukar-Alunite (CA) fault zone and related steeply dipping features in its footwall across several northwest striking faults, including the Good Hope fault. However, the CA fault zone dips 35-45° to the southeast, and as such, cannot be properly projected in a straight line across current topography and several northwest striking faults to the east of Gold Quarry. In addition, most of the major mineralization at Gold Quarry is located in the hanging wall of the CA fault zone, especially where it intersects with steeper dipping antithetics (i.e., Deep Sulfide Feeder faults). If the CA fault zone is truly through-going, then it should be projected along the Tertiary paleosurface and take into account offsets along the several Good Hope parallel faults that exist between Gold Quarry and Maggie Creek. Based upon those projections, we believe that the best potential for high-grade gold deposits of significant size exists in the southeast end of the Maggie Creek project, under post-mineral Carlin Formation cover. See the figures below for more information.

 

Figure 1. Plan and cross-sectional view of Nevada Gold Mines’ Gold Quarry deposit.

 

Figure 2. Maggie Creek project and target area.

 

George Bee, President and CEO stated, “This drill target is a well-thought out and promising effort to discover the next high grade gold deposit on the Carlin Trend. Previous operators have encountered lower-grade, near surface mineralization at Maggie Creek, but a new, high-grade discovery could be a game-changer and provide real value to shareholders.”

QA/QC Procedure

U.S. Gold Corp. employs a rigorous QA/QC protocol on all aspects of sampling and analytical procedure. Drill core is checked, logged, marked for sampling and sawn in half. One-half of each drill core is maintained for future reference, and the other half of each drill core is sent to Bureau Veritas, an ISO 17025 accredited laboratory in Reno, Nevada to complete all sample preparation and assaying. Samples are analyzed employing fire assaying with atomic absorption finish for gold, and four-acid ICP-MS analysis for silver and copper. For QA/QC purposes, certified standards, blank samples and sample duplicates are inserted into the sample stream. U.S. Gold Corp. also periodically submits sample pulps to another independent laboratory for check analysis.

COVID-19 Policy

U.S. Gold Corp. recognizes the heightened health risks associated with the current pandemic. At this stage of the CK Gold Project development, focusing largely on the gathering of information from the field, our personnel, contractors and consultants do not need to come into close contact with others apart from work within individual pods such as the drill crew and core logging personnel. Much of our work is conducted outdoors and physically separated. Meetings are conducted from remote locations using available video conferencing software. When it is necessary for individuals to meet or visit facilities, health guidelines are followed to avoid and minimize the risk of spreading the COVID-19 virus. We take the health and safety of all those associated with our activities very seriously. If necessary, we will suspend activities and observe quarantine regimens until any health uncertainty passes.

About U.S. Gold Corp.

U.S. Gold Corp. is a publicly traded, U.S. focused gold exploration and development company. U.S. Gold Corp. has a portfolio of exploration properties. Copper King, now the CK Gold Project, is located in Southeast Wyoming and has a Preliminary Economic Assessment (PEA) technical report, which was completed by Mine Development Associates available on the US. Gold Corp. website. Keystone and Maggie Creek are exploration properties on the Cortez and Carlin Trends in Nevada. The Challis Gold Project is located in Idaho. For more information about U.S. Gold Corp., please visit www.usgoldcorp.gold.

Safe Harbor

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimated,” and “intend,” among others. These forward-looking statements are based on U.S. Gold Corp.’s current expectations, and actual results could differ materially from such statements. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks arising from: the prevailing market conditions for metal prices and mining industry cost inputs, environmental and regulatory risks, risks faced by junior companies generally engaged in exploration activities, whether U.S. Gold Corp. will be able to raise sufficient capital to implement future exploration programs, COVID-19 uncertainties, and other factors described in the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed with the Securities and Exchange Commission, which can be reviewed at 

www.sec.gov

. The Company has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control. The Company makes no representation or warranty that the information contained herein is complete and accurate and we have no duty to correct or update any information contained herein.

Cautionary Note to U.S. Investors Concerning Mineral Resources

We may use certain terms on this press release, which are defined in Canadian Institute of Metallurgy guidelines, the guidelines widely followed to comply with Canadian National Instrument 43–101– Standards of Disclosure for Mineral Projects (“NI 43–101”). We advise U.S. investors that these terms are not recognized by the United States Securities and Exchange Commission (the “SEC”). However, the SEC normally only permits issuers to report mineralization that does not constitute “reserves” by SEC standards as in place tonnage and grade without reference to unit measures. Note that a preliminary economic assessment is preliminary in nature, and it includes Inferred mineral resources that are considered too speculative geologically to have the economic considerations applied that would enable them to be classified as mineral reserves, and there is no certainty that the preliminary assessment will be realized.

Photo – https://mma.prnewswire.com/media/1480291/US_Gold_Corp_1.jpg
Photo – https://mma.prnewswire.com/media/1480292/US_Gold_Corp_2.jpg

For additional information, please contact:
U.S. Gold Corp. Investor Relations:
+1-800-557-4550
[email protected] 
www.usgoldcorp.gold

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/us-gold-corp-announces-new-targets-for-upcoming-commencement-of-drilling-at-maggie-creek-carlin-gold-belt-in-nevada-301263673.html

SOURCE U.S. Gold Corp.

Posted on

Quotient to Announce First Quarter 2021 Financial Results on May 5, 2021

Quotient to Announce First Quarter 2021 Financial Results on May 5, 2021

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Quotient Technology Inc. (NYSE: QUOT) today announced it will report its financial results for the first quarter ended March 31, 2021, after the market closes on Wednesday, May 5, 2021.

Quotient will issue a press release and post a Stockholder Letter on its website’s Investor Relations section at http://investors.quotient.com. Following the release of financials, management will host a webcast conference call to discuss the results at 5:00 p.m. EDT/ 2:00 p.m. PDT.

To access the call, we encourage you to pre-register using this link: Quotient Q1 2021 Earnings Pre Registration. After registering, a confirmation will be sent via email and will include dial-in details and a unique PIN code for entry to the call. To avoid long wait times, we suggest registering at least one day in advance or at minimum 15 minutes before the start of the call to receive your unique PIN code. Registration will be open throughout the live call. You may also access the call and register with a live operator by dialing (866) 270-1533, or (412) 317-0797 outside the U.S., at least 15 minutes prior to the 2:00 p.m. PDT start time.

A live webcast will be available at http://investors.quotient.com under the Events and Presentations menu. A replay of the webcast will be available on the website following the conference call.

About Quotient Technology Inc.

Quotient Technology (NYSE: QUOT) is the leading digital media and promotions technology company that creates cohesive omnichannel brand-building and sales-driving opportunities to deliver valuable outcomes for advertisers, retailers and consumers. The Quotient platform is powered by exclusive consumer spending data, location intelligence and purchase intent data to reach millions of shoppers daily and deliver measurable, incremental sales.

Quotient partners with leading advertisers and retailers, including Clorox, Procter & Gamble, General Mills, Unilever, Albertsons Companies, CVS, Dollar General and Peapod Digital Labs, a company of Ahold Delhaize USA. Quotient is headquartered in Mountain View, California, and has offices across the US as well as in Bangalore, Paris, London and Tel Aviv. For more information visit www.quotient.com.

Quotient and the Quotient logo are trademarks or registered trademarks of Quotient Technology Inc. and its subsidiaries in the United States and other countries. Other marks are the property of their respective owners.

Investor Relations Contact:

Christine Marchuska

Vice President, Investor Relations

Phone: 917-232-0852

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Discount/Variety Marketing Advertising Supermarket Communications Software Retail Data Management

MEDIA:

Logo
Logo
Posted on

With New China Warehouse, TCM Cuts E-commerce Costs, Streamlines Shipping, Boosts Product Quality

Consumers benefit from TCM’s direct product QA; e-commerce stores benefit from double-digit cost savings and more

HERZLIYA PITUACH, Israel, April 07, 2021 (GLOBE NEWSWIRE) — E-commerce aggregator Technology Commerce Management (TCM) today announced it has leased a 32,000 square foot warehouse in Ningbo Port, China. Fully managed by TCM, the warehouse eliminates the costs, risks and inefficiencies of third-party warehouse management, while dramatically improving product quality assurance and streamlining the shipping process. TCM’s move results in myriad benefits for the company’s e-commerce stores, as well as consumers.

The Ningbo Port warehouse enables TCM to centralize its supply chain for all products sold by its e-commerce businesses from more than 180 suppliers. As a result, TCM will:

  • Ensure all products meet its own rigorous quality standards
  • Streamline inventory production and reduce the need for costly inventory storage
  • Reduce warehouse costs by at least 50 percent and shipping costs by as much as 30 percent
  • Enable direct-to-consumer shipping for TCM-owned off-Amazon stores
  • Increase consumer access to products not currently allowed on Amazon’s marketplace, such as anti-bacterial products

In keeping with the company’s mission to share the massive wealth generated by the e-commerce groundswell, TCM will funnel 20 percent of its related shipping-cost savings to philanthropic organizations, such as youth-at-risk programs and those supporting children with disabilities. TCM will also gradually move toward using sustainable shipping materials, which correlates with the company’s core values.

“We made this bold, timely decision to tackle the quality issues and cost barriers we encounter with warehousing and shipping,” said TCM co-founder Gabi Bar. “Having our own warehouse on location in China puts TCM fully in control of product quality, as well as shipping timeliness – both of which are so important to building customer loyalty and business growth. It also opens up new opportunities for our off-Amazon stores on Shopify, Magento, eBay and other marketplaces to shorten delivery times to consumers.”

From the consumer point of view, TCM’s warehousing strategy ensures delivered products will be of the highest quality. This keeps customers happy and encourages them to order again.

From an e-commerce business perspective, TCM’s strategy improves cash flow management for high-growth stores, reduces the amount of advance stock required for typical fulfillment processes and speeds up most delivery times to consumers.

About TCM

Technology Commerce Management (TCM) delivers the e-commerce aggregator industry’s first predictive, AI-driven e-commerce performance optimization. Using a combination of big data, artificial intelligence (AI) and machine learning (ML), TCM identifies, qualifies, acquires and optimizes e-commerce businesses with the highest empirical probability of maximizing wealth creation and ROI for all stakeholders. Founded in 2016 and based in Israel, TCM now operates e-commerce businesses on Amazon, Shopify, eBay, Walmart, Wayfair, WooCommerce and more. Learn more about TCM at www.tcmdigital.com and follow TCM onLinkedIn, Facebook, Twitter and YouTube.

Media Contact: 
Michelle Allard McMahon 
Rainier Communications 
+1 781-718-3248 
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5fa884b2-aa08-4d6a-8ccf-0e3cc0849d1d



Posted on

E-commerce Aggregator TCM Fortifies Growing House of Brands with Three New Online Store Acquisitions

TCM SuperBrain™ AI technology drives optimization and growth in niche superstars

HERZLIYA PITUACH, Israel, April 07, 2021 (GLOBE NEWSWIRE) — Tech-first e-commerce aggregator Technology Commerce Management (TCM) today announced that it added three new niche online stores to its rapidly expanding house of brands. The new stores bring the total number of outlets in TCM’s portfolio to 26 with plans to increase the stores’ revenue by an estimated 30 percent using its artificial intelligence (AI)-driven optimization.

“We are very optimistic about the prospects of these acquisitions,” said Gabi Bar, TCM co-founder. “They are already performing very well, with combined annual revenues approaching $6 million. But, with TCM’s AI and machine learning (ML) provided by our SuperBrain Technology™, we expect sales and revenue for each store to grow dramatically in 2021 and beyond.”

TCM will leverage its proprietary AI and ML technologies in combination with the company’s comprehensive ecosystem to grow sales and profitability for these new TCM brands. The three acquisitions will be optimized for accelerated growth using the following strategies:

  • Adding product variation and improving inventory management
  • Increasing sales with AI-driven PPC tools
  • Penetrating eBay, Walmart, Rakuten, and other US-based off-Amazon marketplaces
  • Identifying and introducing new products through the company’s AI/ML product discovery system
  • Expanding sales strategy to include global Amazon markets
  • Improving websites and establishing or expanding social networks marketing

Using its comprehensive ecosystem, TCM has a history of identifying undervalued online stores, acquiring them at aggressive prices, and then optimizing their sales and marketing strategies to maximize revenues and profits.

About TCM  
Technology Commerce Management (TCM) delivers the e-commerce aggregator industry’s first predictive, AI-driven e-commerce performance optimization. Using a combination of big data, artificial intelligence (AI) and machine learning (ML), TCM identifies, qualifies, acquires and optimizes e-commerce businesses with the highest empirical probability of maximizing wealth creation and ROI for all stakeholders. Founded in 2016 and based in Israel, TCM now operates e-commerce businesses on Amazon, Shopify, eBay, Walmart, Wayfair, WooCommerce and more. Learn more about TCM at www.tcmdigital.com and follow TCM on LinkedIn, Facebook, Twitter and YouTube.   

Media Contact:  
Michelle Allard McMahon  
Rainier Communications  
+1 781-718-3248  
[email protected] 

 



Posted on

Proofpoint to Report First Quarter 2021 Financial Results

SUNNYVALE, Calif., April 07, 2021 (GLOBE NEWSWIRE) — Proofpoint, Inc., (NASDAQ: PFPT), a leading cybersecurity and compliance company, today announced it will issue a press release reporting financial results for the first quarter ended March 31, 2021, after the close of the market on April 29, 2021.

Proofpoint will host a conference call and live webcast to discuss those financial results for investors and analysts at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on April 29, 2021. To access the conference call, dial (800) 458-4121 for the U.S. or Canada and (929) 477-0324 for international callers with conference ID #8858231. The webcast will be available live on the Investors section of the company’s website at investors.proofpoint.com. An audio replay of the call will also be available beginning at approximately 4:30 p.m. Pacific Time on April 29, 2021, until 8:59 p.m. Pacific Time on May 13, 2021, by dialing (844) 512-2921 for the U.S. or Canada or (412) 317-6671 for international callers, and entering passcode #8858231. In addition, an archived webcast will be available on the Investors section of the company’s website at investors.proofpoint.com.

About Proofpoint, Inc.
Proofpoint, Inc. (NASDAQ: PFPT) is a leading cybersecurity and compliance company that protects organizations’ greatest assets and biggest risks: their people. With an integrated suite of cloud-based solutions, Proofpoint helps companies around the world stop targeted threats, safeguard their data, and make their users more resilient against cyber attacks. Leading organizations of all sizes, including more than half of the Fortune 1000, rely on Proofpoint for people-centric security and compliance solutions that mitigate their most critical risks across email, the cloud, social media, and the web. More information is available at www.proofpoint.com.

Proofpoint is a trademark or registered trademark of Proofpoint, Inc. in the U.S. and other countries. All other trademarks contained herein are the property of their respective owners.



Media Contact:



Kristy Campbell
Proofpoint, Inc.
408-517-4710
[email protected]



Investor Contact:



Jason Starr
Proofpoint, Inc.
408-585-4351
[email protected]